DaVita

DaVita Inc. is a leading provider of kidney dialysis services, focusing on patients with chronic kidney failure and end-stage renal disease. The company operates a vast network of outpatient dialysis centers, clinical laboratories, and offers a range of related services, including outpatient, inpatient, and home-based hemodialysis. DaVita's operations extend beyond the United States, with facilities in multiple countries, serving hundreds of thousands of patients annually. The company is dedicated to enhancing patient quality of life through innovative clinical care and personalized treatment plans. Additionally, DaVita engages in various community support initiatives and is recognized for its leadership development and social responsibility efforts. Founded in 1994 and headquartered in Denver, Colorado, DaVita has established itself as a dominant player in the dialysis market, holding a significant share in both patient care and clinic operations.

Singleton Cox

Vice President, Corporate Development

10 past transactions

Brasnefro

Acquisition in 2025
Brasnefro is part of this global healthcare group. Brasnefro Participações S.A. a division of Fresenius Medical Care and operates dialysis clinics

Egenesis

Series D in 2024
Egenesis Inc. is a biotechnology company focused on gene editing and genome engineering to create human transplantable organs, tissues, and cells. Established in 2015 and headquartered in Cambridge, Massachusetts, with an additional office in New York City, Egenesis aims to address the global organ shortage by developing solid organs and therapeutic cell transplantation solutions for various diseases. The company utilizes a gene editing platform that incorporates techniques such as single-cell cloning and somatic cell nuclear transfer, which are essential for creating human-compatible organ tissues and cells. Egenesis is particularly engaged in advancing programs related to kidney and islet cell transplantation, striving to provide alternative treatment options for patients with life-threatening conditions.

Rockwell Medical

Post in 2022
Rockwell Medical operates as a biopharmaceutical company focused on end-stage renal disease (ESRD) and chronic kidney disease (CKD). It offers Triferic, an iron therapy for dialysis patients, and Calcitriol, an active vitamin D injection for managing hypocalcemia in hemodialysis patients. Additionally, Rockwell Medical manufactures and distributes hemodialysis concentrates such as CitraPure citric acid concentrate and SteriLyte bicarbonate concentrate, along with ancillary products like blood tubing and dialyzers. These products are used to maintain human life by removing toxins and replacing critical nutrients during dialysis treatments. The company sells its products directly and through independent sales agents and distributors, targeting senior management of dialysis companies, service providers, nephrologists, and other healthcare professionals involved in dialysis care. Rockwell Medical was founded in 1994 and is headquartered in Wixom, Michigan.

MedSleuth

Acquisition in 2022
MedSleuth is focused on enhancing patient involvement in healthcare through its innovative medical record platform. This web-based system is designed to improve the quality and efficiency of patient triage and transplant management. By collecting relevant clinical and demographic information from candidates, MedSleuth facilitates the sharing of this data with participating transplant centers. This approach aids physicians and care teams in streamlining the evaluation process for kidney and liver transplant patients, ultimately leading to better healthcare outcomes.

Northwest Physicians Network

Acquisition in 2017
Northwest Physicians Network of Washington LLC is an independent physician association based in Tacoma, Washington, that includes over 1,000 primary and specialty-care physicians. Founded in 1995, the organization focuses on providing coordinated health care services by connecting physicians, hospitals, labs, and patients electronically and securely. Its offerings encompass utilization management, case management, and disease management. The network aims to enhance patient choice and convenience by facilitating access to a range of health care professionals and outpatient centers across multiple locations. Additionally, Northwest Physicians Network supports its physician members by providing resources and strength from being part of a larger multispecialty provider network, enabling them to deliver quality care without corporate restrictions. As of November 2017, it operates as a subsidiary of DaVita Medical Group.

Purity Dialysis

Acquisition in 2017
Purity Dialysis Centers Inc. specializes in providing kidney dialysis services, operating multiple outpatient facilities across Southeastern Wisconsin, including locations in Brookfield, Fort Atkinson, Germantown, Menomonee Falls, Mukwonago, Oconomowoc, Watertown, and Waukesha. The company offers hemodialysis treatments and training for in-home peritoneal dialysis, allowing patients to manage their care in the comfort of their homes. This approach caters to healthier patients, giving them the option to receive necessary treatment without frequent visits to a dialysis center. Based in Delafield, Wisconsin, Purity Dialysis is committed to meeting the needs of its patients through dedicated and experienced care. It functions as a subsidiary of DaVita Kidney Care.

Family Health Care of Central Florida

Acquisition in 2016
Family Health Care of Central Florida has been providing Osceola County with comprehensive health care for over 30 years. The group currently has three convenient locations to serve patients. Kissimmee, St. Cloud, and Poinciana offices are staffed with board certified medical professionals specializing in family medicine, with an emphasis on the care of children, disease management, and the care of senior citizens.

CVRx

Series F in 2013
CVRx, Inc. is a medical device company based in Minneapolis, Minnesota, that specializes in implantable technology for treating high blood pressure and heart failure. The company develops Barostim, a proprietary neuromodulation therapy that activates the body's natural reflexes to regulate blood pressure and address the progression of heart failure. This therapy is delivered through a long-lasting implant system that is tailored to meet individual patient needs. CVRx also manufactures the Rheos implantable pulse generator and associated components, which facilitate the delivery of activation energy to the carotid arteries. Founded in 2000, CVRx primarily serves patients and healthcare professionals in the United States and several European countries, focusing on minimally invasive solutions for cardiovascular diseases.

HealthCare Partners

Acquisition in 2012
Since 1992, HealthCare Partners has been committed to developing innovative models of healthcare delivery that improve our patients' quality of life while containing healthcare costs. Our strength is in our steadfast commitment to our guiding principle of coordinated care. Our physicians strive daily to bring the benefits of coordinated care to more than 575,000 managed care patients in California, who represent the diversity of cultures, socioeconomic groups, ages, and health statuses in the communities we serve.

Gambro Healthcare

Acquisition in 2004
Gambro is a global medical technology company that manufactures products for Dialysis treatment.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.